Tylenol maker Kenvue blasts Trump administration's autism claim
Summary
A company that sells Tylenol, called Kenvue, is defending the drug's safety after the Trump administration suggests a link between Tylenol and autism. Kenvue states that acetaminophen, Tylenol's main ingredient, is safe for pregnant women, and backed by global health experts. The company's stock has dropped amid concerns about these claims.Key Facts
- Kenvue sells Tylenol and other consumer health products and is a spin-off from Johnson & Johnson.
- The Trump administration is suggesting a link between taking Tylenol during pregnancy and autism.
- Kenvue argues that there is no credible evidence showing that acetaminophen causes autism.
- Kenvue claims acetaminophen is considered safe for pregnant women by health professionals.
- The discussion has impacted Kenvue’s stock, which dropped over 6% on the news.
- Kenvue's revenue heavily relies on its self-care segment, which includes Tylenol.
- President Trump and his health officials plan to discuss this topic at a White House event.
- Kenvue's business strategy is affected as the controversy threatens market share gains for Tylenol.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.